17-Jul-2026
No headlines found.
No press releases found.
No news found.
The fund tracks the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The Index is designed to provide exposure to equity securities of exchange-listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The Index constituents are determined by an Index committee that looks at companies focusing on the application of genetic technologies to prevent and treat disease the applications of human genetic technologies to new classes of consumer products personalized for each individual the transformation of agriculture, aquaculture, and food production, creating healthier and more sustainable models for feeding the growing global population biological re-engineering used to produce an increasing percentage of the physical inputs needed for manufacturing and/or DNA as a storage solution (collectively, BioRevolution Activities).
WisdomTree Biorevolution trades on the BATS stock market under the symbol WDNA.
As of July 17, 2026, WDNA stock price was flat at $19.83 with 48 million shares trading.
WDNA has a market cap of $2.58 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, WDNA traded as high as $21.70 and as low as $11.20.
WDNA has outperformed the market in the last year with a return of +46.5%, while the SPY ETF gained +19.5%. In the last 3 month period, WDNA beat the market returning +6.7%, while SPY returned +4.9%. However, in the most recent 2 weeks WDNA has underperformed the stock market by returning -6.2%, while SPY returned -0.2%.
WDNA support price is $19.25 and resistance is $20.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WDNA shares will trade within this expected range on the day.
